Navigation Links
Renewable Oocytes of Mice created hope in Human Fertility Treatment

Using mice as an experimental animal, researchers have discovered that despite its age female mice have a renewable number of oocytes (egg) supply in their ovaries//.

As a preliminary step, this study would pave way for many further discoveries in the field of ovarian stem cell research and women’s fertility treatment – said Professor Jock Findlay from Prince Henry's Institute and Associate Professor Jeff Kerr from Monash's Department of Anatomy and Cell Biology.

The discovery, by Professor Jock Findlay from Prince Henry's Institute and Associate Professor Jeff Kerr from Monash's Department of Anatomy and Cell Biology, has sparked controversy among biologists and challenged the theory, held for more than 50 years, that female mammals are born with a finite number of oocytes (eggs).

Two years ago, international researchers speculated that mice could continue to produce eggs throughout puberty and adulthood. Although their speculation caused debate throughout the scientific community, the scientists could not produce evidence to confirm their idea. However, Professor Findlay and Dr Kerr's research gives support to the theory. Their findings have been published in the July issue of Reproduction.

In the mammalian ovary, reproductive cells called oocytes (eggs) develop within ovarian follicles. In humans, the eggs are believed to die off from late in foetal life, after birth and into adult life. When egg numbers decline towards zero females can no longer reproduce – resulting in the condition we know as menopause.

Professor Findlay, Dr Kerr and their colleagues have found that the total number of eggs in young and normal healthy adult female mice do not decline over time and that overall egg number is maintained for longer than previously thought. Their research suggests that mice have a source of renewable oocytes, Professor Findlay said.

‘The mechanism behind renewable oocytes is still unknown,’ he said. ‘Al
'"/>




Page: 1 2

Related medicine news :

1. Feeding channel created by malaria parasite - a new target for malaria treatments
2. Myth of female impotence created to boost sales
3. Birth mark awareness created by internet helped to treat Cavernous hemangioma
4. Human Genome Project Achieves Technological Triumph
5. First Vaccine Designed for Africa Cleared for Testing in Humans
6. Human gene number increases
7. Scientists found ancient Human Germ Killer
8. New standards for Human Research Safety
9. Human wasting disease linked to a gene
10. The Human Mad Cow Case
11. Human Growth Hormone Found To be Dangerous For Human Use

Post Your Comments:
(Date:12/1/2009)...ESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ -...001 and have expanded over the years serving the t...ility which was originally set up in an area of 20...ces, as part of the suite of services by Max Neema... a valuable offering. ,, The pharmacy inventory...
(Date:12/1/2009)...HINGTON, Dec. 1 Individ...ore likely than those with traditional coverage to...be more engaged in wellness programs, and to be mo...ter in holding down costs, according to survey res...nefit Research Institute (EBRI). ,, At the sam...
(Date:12/1/2009)...RT LAUDERDALE, Fla., Dec. 1 OrbusN...ollment in the randomized clinical trial of the Co...Stent). ,, A prospective, randomized, multicent...f an ablu M inal sirolimus coat ED bio- E n... to 20 sites in Asia, Australia, Europe and South ...
(Date:12/1/2009)...ents in California are unable to successfully obta...ospitals despite recent state legislation intended... study. , Posing as low-income uninsured patient...than one-third of the hospitals they approached an...an those allowed under California law, according t...
(Date:12/1/2009)... Lumension announces general availability... to deliver end-to-end endpoint management capabil...management console architecture. , ...-- Lumension, a global leader in endpoint manageme...® Endpoint Management and Security Suite (LEMS...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
...pril 22 Halo Pharmaceutical, this week announced ...rom The Provident Bank to expand its operations. ,... held full-service, specialty pharmaceutical compa...ed industries. , , "Provident is a respected loc...
...nd mother teams up with the March of Dimes and san...ation campaign , , WHITE PLAINS, N.Y. and SWIFTWA...to hear their baby,s first babbles and coos, there... commonly known as whooping cough. Ms. Lopez has j...
...22 ResMed Inc. (NYSE: RMD ), announced today th...esults for the third quarter and nine months of fi...lease with ResMed,s results will be issued after 1...rence call is scheduled to begin at 1:30 p.m. Paci...
...s larger trials needed to assess therapy over long... News) -- Acupuncture reduces severe dry mouth (xe...ead and neck cancer, a small pilot study suggests....e dental oncology department at the University of ...
...esearch, study finds older people taking NSAIDs mo... April 22 (HealthDay News) -- Research has suggest... disease might want to take daily doses of painkil...ent dementia?, the answer based on our study woul...
...itish Columbia researchers have discovered a "mole... blood stem cell transplants, a procedure currentl...,s lymphoma and aplastic anemia. , During a blood... new blood. The stem cells then need to travel to ...
Other Medicine News:Health News:Halo Pharmaceutical Completes $14.6 Million in Financing from The Provident Bank 2Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 2Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 3Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 4Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 5Health News:ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results 2Health News:Acupuncture Cuts Dry Mouth in Cancer Patients 2Health News:Painkillers May Not Protect Against Dementia 2Health News:Painkillers May Not Protect Against Dementia 3
(Date:12/1/2009)... Dec. 1 CCS Medical, Inc. a leadin... today announced that it has received approval fro...of Delaware (the "Court") for its bidding procedur...ale of substantially all of its assets. ,, Purs...t approved bidding procedures for the sale of subs...
(Date:12/1/2009)... 1 CEL-SCI Corporation (...nd a developer of vaccines and therapeutics for th... announced today that it has retained the services...n (CRO) to run CEL-SCI,s upcoming Phase III clinic...with the Company,s lead product candidate, Multiki...
(Date:12/1/2009)... Dec. 1 MedQuist Inc. ...-enabled clinical documentation services, today an...dial Design, Inc. has been integrated with SpeechQ...cognition system. The solution is being demonstrat...SNA) convention November 29 through December 2. ...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 1Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 2EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 1EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 2EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 3EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 4YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 1YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 2YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 3YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 4
...-Company to Host Conference Call at 9:00 a.m. EDT-... Corp. (Nasdaq: MEMY ) today announced top-line d...d, placebo-controlled Phase 2a study,of MEM 1003, ...zheimer,s,disease. The trial enrolled 183 subjects... 40 centers in the United States and included mono...
...ORLANDO, Fla., Oct. 13 Acutely ill, hospitalized,...rovement in symptoms,after taking INVEGA(TM) (pali...SEROQUEL(R)(a) (quetiapine) and placebo. Symptom i...ve days into therapy and continued,through the end...inary data,presented today at the 20th Annual U.S....
Other Medicine Technology:Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 2Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 4INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 2INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 3INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 4INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 5INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 6INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 7
Bra With Cups
Bandeau Bra
Medical Cotton Bra
Compression Bra
Medicine Products: